TY  - BOOK
AU  - DeGeorge, Lindsey M
TI  - Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency
SN  - 0744-8481
PY  - 2017///
KW  - *Analgesics, Opioid/ae [Adverse Effects]
KW  - *Drug Overdose/dt [Drug Therapy]
KW  - *Emergency Medical Services/mt [Methods]
KW  - *Naloxone/ad [Administration & Dosage]
KW  - Administration, Intranasal/mt [Methods]
KW  - Humans
KW  - Naloxone/tu [Therapeutic Use]
KW  - Narcotic Antagonists/ad [Administration & Dosage]
KW  - Narcotic Antagonists/tu [Therapeutic Use]
KW  - Students/sn [Statistics & Numerical Data]
KW  - Universities/og [Organization & Administration]
KW  - Universities/td [Trends]
KW  - MedStar Washington Hospital Center
KW  - Emergency Medicine
KW  - Journal Article
N2  - Opioid abuse is a growing and significant public health concern in the United States. Naloxone is an opioid antagonist that can rapidly reverse the respiratory depression associated with opioid toxicity. Georgetown University's collegiate-based emergency medical services (EMS) agency recently adopted a protocol, allowing providers to administer intranasal naloxone for patients with suspected opioid overdose. While normally not within the scope of practice of basic life support prehospital agencies, the recognition of an increasing epidemic of opioid abuse has led many states, including the District of Columbia, to expand access to naloxone for prehospital providers of all levels of training. In particular, intranasal naloxone is a method of administering this medication that potentially avoids needlestick injuries among EMS providers. Universities with collegiate-based EMS agencies are well positioned to provide life-saving treatments for patients acutely ill from opioid overdose
UR  - https://dx.doi.org/10.1080/07448481.2016.1277730
ER  -